Mercury Nursing Home And Medipharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.30 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 133.76%
- Profit Growth 94.26%
- Ebitda 115.39%
- Net Worth -2.78%
- Total Assets -0.31%
About Mercury Nursing Home And Medipharma
Mercury Nursing Home And Medipharma Private Limited (MNHAMPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 June 2009 and has a history of 15 years and eight months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Dhruv Singh and Anjali Singh serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100UP2009PTC037592
-
Company No.
037592
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jun 2009
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Mercury Nursing Home And Medipharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhruv Singh
|
Director | 15-Jun-2009 | Current |
|
Anjali Singh
|
Director | 15-Jun-2009 | Current |
Financial Performance of Mercury Nursing Home And Medipharma.
Mercury Nursing Home And Medipharma Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 133.76% increase. The company also saw a substantial improvement in profitability, with a 94.26% increase in profit. The company's net worth dipped by a decrease of 2.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mercury Nursing Home And Medipharma?
In 2017, Mercury Nursing Home And Medipharma had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Laetitia Estate Resorts Private LimitedDhruv Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mercury Nursing Home And Medipharma?
Unlock and access historical data on people associated with Mercury Nursing Home And Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mercury Nursing Home And Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mercury Nursing Home And Medipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.